FDA Requests Removal of All Ranitidine Products (Zantac) from the Market | FDA
RT
:
FDA requests market withdrawal of all remaining prescription and OTC ranitidine (Zantac) products on the U.S. market. This means that ranitidine will not be available for use in the U.S. go.usa.gov/xvC75
Cancer Nanotechnology
Hace 8 horas
No hay comentarios:
Publicar un comentario